AANS Beyond 2021: Full Collection-Building an Intraoperative Mapping Program

Video Transcription

Video Summary

In this video, the speaker discusses the topic of building an interoperative mapping program for glioma surgery. He emphasizes the importance of early intervention and extended resection in improving overall survival for low-grade gliomas. The speaker presents various studies that support this concept and highlight the benefits of aggressive surgical resection, including improved quality of life and lower malignant transformation rates.<br /><br />For higher-grade gliomas, the speaker discusses the use of fluorescence-guided surgery and the benefits of greater extent of resection in improving survival rates. He also addresses the role of genetics in determining the response to cytoreduction and the need to consider risk-benefit ratios based on the tumor's genetic background.<br /><br />The speaker explores different surgical approaches for gliomas located in the insula, thalamus, and other regions of the brain. He discusses the importance of careful patient positioning, utilizing natural subarachnoid planes, and the use of intraoperative technologies such as stimulation mapping, fluorescence-guided surgery, intraoperative MRI, ultrasound, and CT.<br /><br />The speaker describes the process of building a mapping program and emphasizes the importance of collaboration with neuroanesthesia, careful case selection, and adherence to a defined mapping protocol. He also discusses the learning curve associated with developing a mapping program and the gradual improvement in outcomes over time.<br /><br />Overall, the video provides insights into the benefits of extended resection and an interoperative mapping program in glioma surgery, highlighting the importance of individualized approaches and multidisciplinary collaboration in improving patient outcomes.

Keywords

interoperative mapping program

glioma surgery

early intervention

extended resection

low-grade gliomas

fluorescence-guided surgery

genetics and gliomas